Hi [[ session.user.profile.firstName ]]

Cell Culture Contamination Part 3

Recent studies have shown that at least 20% of the animal cell cultures currently in use in the US are contaminated by either microorganisms or other cell lines! This three part live, on-line seminar series will review the scope of this major problem and examine some of its causes and techniques for
Recent studies have shown that at least 20% of the animal cell cultures currently in use in the US are contaminated by either microorganisms or other cell lines! This three part live, on-line seminar series will review the scope of this major problem and examine some of its causes and techniques for avoiding it.  It will also explore some key, easy to employ strategies for preventing these losses by careful culture management.
Recorded Mar 3 2011
41 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Hilary Sherman
Presentation preview: Cell Culture Contamination Part 3
Recommended for you:
  • Date
  • Rating
  • Views
  • Impact measurement; from counting numbers to actionable insights Impact measurement; from counting numbers to actionable insights Jan Keuppens (VP Integrated Execution, Across Health) and Christophe Brock (Senior Consultant, Across Health) Recorded: May 31 2016 52 mins
    The key topics that will be discussed during this interactive webinar include:

    •The AH impact measurement approach; Exposure, engagement, conversion and effectiveness
    •Defining KPIs relevant to your brand strategy & objectives
    •Best case – Worst case
    •Creating a dashboard
    •Q&A
  • Blinded By the Light - The Need for SSL Inspection in the Age of Enlightenment Blinded By the Light - The Need for SSL Inspection in the Age of Enlightenment Greg Mayfield, Director, Product Marketing, Blue Coat; Spencer Wilcox, Excelon; Sammy Basu, Warner Bros. Entertainment Group; Recorded: May 26 2016 58 mins
    Starting in earnest after the "Snowden Revelations" 2013, more and more service providers such as Google, Yahoo and Amazon have been embracing SSL by default. Whether in search, cloud services or webmail access, these providers have been instrumental in their support of a more secure and obfuscated web. But what does that mean for the enterprise information security professional? While the providers have "seen the light", have we become blinded by it? To ensure the inspection and subsequent protection of data streams in and out of our organizations, we need the ability to inspect encrypted traffic for policy violations or other malicious activity while still ensuring multi- jurisdictional rights to privacy. Join Blue Coat and (ISC)2 on May 26, 2016 for a roundtable discussion exploring methods and mechanisms for addressing SSL inspections and the search for malicious activity.
  • Using Data Security to address HIPAA and HITECH Regulations Using Data Security to address HIPAA and HITECH Regulations Derek Tumulak, Vormetric VP of Product Management and Tricia Pattee, HOSTING Product Manager Recorded: May 26 2016 38 mins
    Learn how data encryption and encryption key management address compliance for healthcare providers and payers. Join Derek Tumulak, VP Product Management at Vormetric, and Tricia Pattee, HOSTING Product Manager as they discuss how HIPAA/HITECH regulations impact electronic protected health information (PHI) and best practices to safeguard sensitive patient data.

    Discover how:
    • HIPAA and HITECH regulatory mandates impact data security for healthcare institutions
    • Strong encryption and policy-based access controls provide a separation of duties between data security and system administrators
    • Secure key management and policy management ensure consistency in applying policies and encryption keys to both structured and unstructured data
    • Rapid implementation is achieved because encryption is transparent to users, applications, databases and storage systems
    • The HOSTING and Vormetric cloud solution can satisfy HIPAA and HITECH compliance requirements in the cloud
  • Finally -- Evidence-Based Best Practices For Using UV Disinfection Equipment Finally -- Evidence-Based Best Practices For Using UV Disinfection Equipment Dr. William Jarvis MD, Dr. Thomas Kelley MD Recorded: May 25 2016 62 mins
    You wouldn’t operate a ventilator or administer an IV without knowing there are scientific studies that back up your procedures. You learned best practices supported by scientific research.

    We have the science and consensus to support UV disinfection best practices. Best practices that have resulted in infection rate reductions in real hospital environments.

    Your discussion will be led by esteemed experts Dr. William Jarvis and Dr. Thomas Kelley.

    William Jarvis, MD is a world leader in infection prevention. Among many other accomplishments he worked at the Centers for Disease Control and Prevention for 23 years, and has published over 450 peer reviewed papers. Recently it was said of Dr. Jarvis, “His decades of service and uncompromised commitment to [infection prevention] has lead to changes in how infection control is administered and has saved many lives.”

    Dr. Jarvis will discuss:
    -Most recent CDC and SHEA guidelines, and the metrics involved
    -A review of the science available on UV technologies in the market
    -What to look for when evaluating a UV technology

    Thomas Kelley, MD is Chief of Quality and Clinical Transformation at Orlando Health. He is a practicing primary care physician in Florida and has been a champion of quality improvement his entire career. He developed the first quality improvement council for the residency program when he was a faculty physician training residents at Atlanta Medical Center, and has continued to give his time and expertise to the causes of patient safety and quality care ever since. Colleagues say, “Dr. Kelley is a true champion for quality.”

    Dr. Kelley will discuss:
    -An integrated disinfection program with pulsed xenon enlightening best practices
    -Review of the results from a system-wide deployment of pulsed xenon light technology
    -How they achieved a $3.8M cost avoidance from HAI rate reduction in 12 months
  • How U.S. hospitals Enhance Patient Care with PCoIP & Imprivata technology How U.S. hospitals Enhance Patient Care with PCoIP & Imprivata technology Chris Smith, Imprivata & Patrick Mauro, Teradici Recorded: May 25 2016 61 mins
    Today, hospitals and healthcare organizations are under increasing pressure to revamp the way doctors and clinicians work and the how patients are treated ̶ IT based solutions across medical units work to make patient treatment and medical professional work more efficient and effective.

    Join us for an informative session and hear how leading hospitals have reduced IT costs and increased clinical staff productivity.

    This webinar will share how three medical facilities in the U.S. have successfully:
    •Streamlined clinical workflows with “no click access”
    •Ensured the protection of patient information and compliance requirements with “tap in and out” user authentication and highly secure PCoIP® Zero Clients
    •Increased staff and doctor satisfaction with a consistent user experience that follows them no matter where they need to work
    •Reduced operational costs by deploying PCoIP Zero Clients, PCoIP Management Console Enterprise Edition and Imprivata OneSign® Single Sign On (SSO)
  • In Vitro Characterization of Species Difference of OATP In Vitro Characterization of Species Difference of OATP Na Li, Ph.D. Recorded: May 25 2016 52 mins
    Organic anion-transporting polypeptides (OATPs) play an important role in hepatic uptake of a variety of clinically important drugs. The significant differences in OATP/Oatp-dependent drug transport between human and preclinical species presents a challenge for interspecies extrapolation of drug pharmacodynamics and pharmacokinetics. The assessment of the difference in hepatic uptake between species using an in vitro model is highly desired to support mechanistic studies and to understand the differences observed between species in vivo.

    The Corning® TransportoCells™ model has demonstrated significant value in terms of supporting in vitro assessment of drug interaction with SLC transporters in drug discovery and development. Recently, several animal species of Oatps were introduced into the Corning TransportoCells portfolio. This webinar will focus on the development of the newly available animal species and characterization of the differences in OATP/Oatp in substrate specificity and kinetics using this "thaw and go" model.
  • Care Delivery Transformation Through Telehealth – Growth Opportunities in APAC Care Delivery Transformation Through Telehealth – Growth Opportunities in APAC Natasha Gulati, Kiranjit Kaur Recorded: May 25 2016 51 mins
    Demand for telehealth is on the rise in APAC as healthcare industry stakeholders across the region seek to address challenges of an ageing population and rising healthcare costs. However, market sustainability heavily depends on the establishment of successful business models that provide holistic health and wellness solutions by creating an ecosystem of products and services. In this briefing we will discuss the APAC Telehealth market opportunity with in-depth analysis of technologies, regulations, industry partnerships and business models that will help shape the future of care delivery in the region.
  • How to Spend Your Cloud Security Dollar How to Spend Your Cloud Security Dollar Tricia Pattee, HOSTING Director of Managed Services Recorded: May 19 2016 37 mins
    Join cloud security expert Tricia Pattee on May 19 for a quick, cut-to-the-chase analysis on where to get the most bang for your security buck. The interactive, hour-long discussion will include:

    -The five most common security mistakes
    -Top six areas of security spend
    -How to maximize budget – and minimize risk
    -Hidden cloud security costs

    The presentation will include a Q & A to answer your specific questions about security budgeting and cost management.

    Register today.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Cell Culture Contamination Part 3
  • Live at: Mar 3 2011 7:25 pm
  • Presented by: Hilary Sherman
  • From:
Your email has been sent.
or close
You must be logged in to email this